 There has been a functional repair in culture of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.Phage therapy is being studied for multidrug resistant bacteria in people with CF.A number of small molecules that aim at compensating various mutations of the "CFTR" gene are under development.